Jazz Pharmaceuticals Change in Accounts Payable 2010-2025 | JAZZ
Jazz Pharmaceuticals change in accounts payable for the twelve months ending March 31, 2025 was $-0.022B, a 245.18% decline year-over-year.
- Jazz Pharmaceuticals annual change in accounts payable for 2024 was $-0.02B, a 309.03% decline from 2023.
- Jazz Pharmaceuticals annual change in accounts payable for 2023 was $0.01B, a 185.55% decline from 2022.
- Jazz Pharmaceuticals annual change in accounts payable for 2022 was $-0.011B, a 119.69% decline from 2021.